BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 25780901)

  • 1. Proteomics analysis of bodily fluids in pancreatic cancer.
    Pan S; Brentnall TA; Chen R
    Proteomics; 2015 Aug; 15(15):2705-15. PubMed ID: 25780901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proximal fluid proteomics for the discovery of digestive cancer biomarkers.
    Farina A
    Biochim Biophys Acta; 2014 May; 1844(5):988-1002. PubMed ID: 24184935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts.
    Cuoghi A; Farina A; Z'graggen K; Dumonceau JM; Tomasi A; Hochstrasser DF; Genevay M; Lescuyer P; Frossard JL
    J Proteome Res; 2011 May; 10(5):2664-70. PubMed ID: 21425880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteome of postsurgical pancreatic juice.
    Marchegiani G; Paulo JA; Sahora K; Fernández-Del Castillo C
    Pancreas; 2015 May; 44(4):574-82. PubMed ID: 25875796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
    Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
    Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep Dive on the Proteome of Human Body Fluids: A Valuable Data Resource for Biomarker Discovery.
    Li Y; Xun D; Li L; Wang B; Lv J; Liu H; Zhu L; Ma F; Chen X; Tian S; Ding C
    Cancer Genomics Proteomics; 2021; 18(4):549-568. PubMed ID: 34183388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics as a systems approach to pancreatitis.
    Williams JA
    Pancreas; 2013 Aug; 42(6):905-11. PubMed ID: 23851428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body Fluid Degradomics and Characterization of Basic N-Terminome.
    Sabino F; Hermes O; Auf dem Keller U
    Methods Enzymol; 2017; 585():177-199. PubMed ID: 28109429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer.
    Farrell JJ; Toste P; Wu N; Li L; Wong J; Malkhassian D; Tran LM; Wu X; Li X; Dawson D; Wu H; Donahue TR
    Am J Gastroenterol; 2013 Aug; 108(8):1352-9. PubMed ID: 23752880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical proteomics and new biomarkers in biological fluids].
    González-Buitrago JM; Ferreira L; Muñiz MC
    Med Clin (Barc); 2008 Oct; 131(11):426-34. PubMed ID: 18928725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive proteomic analysis of human pancreatic juice.
    Grønborg M; Bunkenborg J; Kristiansen TZ; Jensen ON; Yeo CJ; Hruban RH; Maitra A; Goggins MG; Pandey A
    J Proteome Res; 2004; 3(5):1042-55. PubMed ID: 15473694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomic analysis of human pancreatic juice: methodological study.
    Zhou L; Lu Z; Yang A; Deng R; Mai C; Sang X; Faber KN; Lu X
    Proteomics; 2007 Apr; 7(8):1345-55. PubMed ID: 17443640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human body-fluid proteome: quantitative profiling and computational prediction.
    Huang L; Shao D; Wang Y; Cui X; Li Y; Chen Q; Cui J
    Brief Bioinform; 2021 Jan; 22(1):315-333. PubMed ID: 32020158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteome-based biomarkers in pancreatic cancer.
    Sun C; Rosendahl AH; Ansari D; Andersson R
    World J Gastroenterol; 2011 Nov; 17(44):4845-52. PubMed ID: 22171124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.
    Pernikářová V; Bouchal P
    Expert Rev Proteomics; 2015; 12(6):651-67. PubMed ID: 26456120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of endoscopic pancreatic function test (ePFT)-collected pancreatic fluid proteins precipitated via ultracentrifugation.
    Paulo JA; Kadiyala V; Gaun A; Sauld JF; Ghoulidi A; Banks PA; Steen H; Conwell DL
    JOP; 2013 Mar; 14(2):176-86. PubMed ID: 23474565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.
    Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA
    J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer.
    Farina A; Dumonceau JM; Frossard JL; Hadengue A; Hochstrasser DF; Lescuyer P
    J Proteome Res; 2009 Jan; 8(1):159-69. PubMed ID: 19055478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome analysis of body fluids for amyotrophic lateral sclerosis biomarker discovery.
    Krüger T; Lautenschläger J; Grosskreutz J; Rhode H
    Proteomics Clin Appl; 2013 Jan; 7(1-2):123-35. PubMed ID: 23129563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.